Bellevue Life Sciences Acquisition (BLAC) Short Interest Ratio & Short Volume → These AI trades triggered this morning (545% return) (From Prosper Trading Academy) (Ad) Free BLAC Stock Alerts $10.71 +0.03 (+0.28%) (As of 04/26/2024 ET) Add Compare Share Share Short InterestStock AnalysisChartCompetitorsFinancialsOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsFinancialsOwnershipSEC FilingsShort InterestSocial Media Bellevue Life Sciences Acquisition Short Interest DataCurrent Short Volume2,200 sharesPrevious Short Volume1,500 sharesChange Vs. Previous Month+46.67%Dollar Volume Sold Short$23,518.00Short Interest Ratio / Days to Cover0.1Last Record DateApril 15, 2024Outstanding Shares5,620,000 sharesFloat Size2,810,000 sharesShort Percent of Float0.08%Today's Trading Volume374,100 sharesAverage Trading Volume27,023 sharesToday's Volume Vs. Average1,384% Short Selling Bellevue Life Sciences Acquisition ? Sign up to receive the latest short interest report for Bellevue Life Sciences Acquisition and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatBLAC Short Interest Over TimeBLAC Days to Cover Over TimeBLAC Percentage of Float Shorted Over Time Ad Prosper Trading AcademyThese AI trades triggered this morning (545% return)If you think a market crash is possible in 2024, I don't know why you're not using this yet. Click Here To Get Your Free Copy Bellevue Life Sciences Acquisition Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/20242,200 shares $23,518.00 +46.7%0.1%0.1 $10.69 3/31/20241,500 shares $15,990.00 +7.1%0.1%0.1 $10.66 3/15/20241,400 shares $14,896.00 No Change0.0%0.1 $10.64 2/29/20241,400 shares $14,896.00 +27.3%0.0%0.1 $10.64 2/15/20241,100 shares $11,627.00 -21.4%0.0%0.1 $10.57 1/31/20241,400 shares $14,840.00 No Change0.0%0.2 $10.60 5/31/20231,800 shares $18,333.00 No Change0.0%0.1 $10.19 5/15/20231,800 shares $18,324.00 No Change0.0%0.1 $10.18 BLAC Short Interest - Frequently Asked Questions What is Bellevue Life Sciences Acquisition's current short interest? Short interest is the volume of Bellevue Life Sciences Acquisition shares that have been sold short but have not yet been covered or closed out. As of April 15th, traders have sold 2,200 shares of BLAC short. 0.08% of Bellevue Life Sciences Acquisition's shares are currently sold short. Learn More on Bellevue Life Sciences Acquisition's current short interest. What is a good short interest percentage for Bellevue Life Sciences Acquisition? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.08% of Bellevue Life Sciences Acquisition's floating shares are currently sold short. Is Bellevue Life Sciences Acquisition's short interest increasing or decreasing? Bellevue Life Sciences Acquisition saw a increase in short interest in April. As of April 15th, there was short interest totaling 2,200 shares, an increase of 46.7% from the previous total of 1,500 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Bellevue Life Sciences Acquisition's float size? Bellevue Life Sciences Acquisition currently has issued a total of 5,620,000 shares. Some of Bellevue Life Sciences Acquisition's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Bellevue Life Sciences Acquisition currently has a public float of 2,810,000 shares. How does Bellevue Life Sciences Acquisition's short interest compare to its competitors? 0.08% of Bellevue Life Sciences Acquisition's shares are currently sold short. Here is how the short interest of companies in the industry of "holding & other investment offices" compare to Bellevue Life Sciences Acquisition: Trailblazer Merger Co. I (0.01%), Bowen Acquisition Corp (0.05%), Golden Star Acquisition Co. (0.01%), Direct Selling Acquisition Corp. (0.01%), Osiris Acquisition Corp. (0.10%), Mars Acquisition Corp. (0.07%), Horizon Space Acquisition I Corp. (0.00%), PowerUp Acquisition Corp. (0.08%), Finnovate Acquisition Corp. (0.01%), two (0.00%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Bellevue Life Sciences Acquisition stock? Short selling BLAC is an investing strategy that aims to generate trading profit from Bellevue Life Sciences Acquisition as its price is falling. BLAC shares are trading up $0.03 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Bellevue Life Sciences Acquisition? A short squeeze for Bellevue Life Sciences Acquisition occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of BLAC, which in turn drives the price of the stock up even further. How often is Bellevue Life Sciences Acquisition's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BLAC, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: TBMC Short Interest BOWN Short Interest GODN Short Interest DSAQ Short Interest OSI Short Interest MARX Short Interest HSPO Short Interest PWUP Short Interest FNVT Short Interest TWOA Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:BLAC) was last updated on 4/28/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressJeff Bezos Just Humiliated Elon MuskInvestorPlaceThe World's First "$20 Trillion Drug?"Behind the Markets